glp-1 telehealth crackdown news The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the Telehealth booms on surging GLP-1
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

















02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)










